George Kemble - Executive Chairman, Director at Sagimet Biosciences Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chairman, Director
Issuer Symbol
SGMT on Nasdaq
All Insider Reports
All Insider Reports

George Kemble - trading volume in the past year for Sagimet Biosciences Inc.

Holdings reported by George Kemble for Sagimet Biosciences Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series A Common Stock 81,005 $623,268 $7.69 20 Nov 2025 Direct
Stock Option (Right to Buy) 32,250 09 Jun 2025 Direct Series A Common Stock

Transactions reported by George Kemble for Sagimet Biosciences Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.